Application value of chromosomal microarray analysis for the detection of low-level mosaicisms in amniotic fluid samples and analysis of rare cases.
10.3760/cma.j.cn511374-20241225-00685
- Author:
Huiyuan SHAO
1
,
2
;
Zongyu MIAO
;
Hong WU
;
Lei LI
;
Xiaoyan LIU
;
Yuping WANG
;
Lihua JIANG
Author Information
1. Department of Laboratory Medicine, Yantai Yu Huang Ding Hospital, Yantai, Shandong 264000, China. jlh926@
2. com.
- Publication Type:Journal Article
- MeSH:
Humans;
Female;
Amniotic Fluid/metabolism*;
Pregnancy;
Mosaicism/embryology*;
Prenatal Diagnosis/methods*;
Adult;
In Situ Hybridization, Fluorescence;
Microarray Analysis/methods*;
Karyotyping;
Retrospective Studies;
Male
- From:
Chinese Journal of Medical Genetics
2025;42(4):441-445
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To assess the value of chromosomal microarray analysis (CMA) for the detection of low-level mosaicisms in amniotic fluid samples, and to retrospectively analyze the rare cases of mosaicisms.
METHODS:Chromosomal karyotype of the fetus was determined by G-banding analysis of cultured amniotic fluid cells. CMA was used to detect copy number variation of fetal chromosomes, and fluorescence in situ hybridization (FISH) was used to determine the proportion of fetal chromosomal mosaicisms in uncultured amniotic fluid cells.
RESULTS:Among 825 prenatal samples, 4 cases of true fetal mosaicisms were detected, which yielded an incidence of 0.48%. Two cases were sex chromosomal mosaicisms, and two were autosomal mosaicisms, which involved chromosomes 8 and 9, respectively. All cases were verified by G-banding analysis of cultured amniotic fluid cells, CMA, and/or FISH.
CONCLUSION:CMA has a great value for detecting low-level mosaicisms in amniotic fluid samples, though the positive results need to be verified by other techniques and should be interpreted with caution. The review of rare cases can provide a basis for prenatal genetic counseling.
